e-learning
resources
Virtual 2021
05.09.2021
Tuberculosis, COVID-19 and other comorbidities
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus
A. Polyakova (Moscow, Russian Federation), M. Tihonova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), A. Tihonov (Moscow, Russian Federation), N. Chernyh (Moscow, Russian Federation)
Source:
Virtual Congress 2021 – Tuberculosis, COVID-19 and other comorbidities
Session:
Tuberculosis, COVID-19 and other comorbidities
Session type:
E-poster
Number:
1035
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Polyakova (Moscow, Russian Federation), M. Tihonova (Moscow, Russian Federation), V. Romanov (Moscow, Russian Federation), A. Tihonov (Moscow, Russian Federation), N. Chernyh (Moscow, Russian Federation). Mesodiencephalic modulation in the treatment of XDR TB patients with concomitant type II diabetes mellitus. 1035
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Effectiveness of mesodiencephalic modulation in treatment of XDR TB patients with concomitant type II diabetes mellitus
Source: International Congress 2019 – Extra-pulmonary tuberculosis and comorbidities
Year: 2019
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Clinical manifestations and efficacy MDR/XDR tuberculosis in patients with different type’s of diabetes mellitus
Source: International Congress 2015 – Case series and clinical conundrums in TB
Year: 2015
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Effectiveness of lung surgery in MDR TB patients with diabetes mellitus
Source: International Congress 2016 – Open problems in thoracic surgery
Year: 2016
The evaluation of tuberculosis risk in diabetes mellitus patients in a high incidence of tuberculosis region
Source: Annual Congress 2010 - Tuberculosis: metabolic insights
Year: 2010
Impact of diabetes mellitus on MDR-TB outcome
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Efficacy of treatment of MDR/XDR TB patients with diabetes mellitus
Source: International Congress 2015 – TB treatment: new drugs and drug resistance
Year: 2015
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Comparison of the clinical manifestations of tuberculosis in patients with different type’s of diabetes mellitus and without it
Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe
Year: 2016
Prevalence and factors associated with diabetes mellitus among tuberculosis patients: a nationwide cohort
Source: Eur Respir J 2016; 48: 264-268
Year: 2016
Outcomes among patients with pulmonary TB with diabetes mellitus treated with anti-TB drugs of 1
st
line
Source: Annual Congress 2010 - Adverse events of antituberculosis treatment and comorbidities
Year: 2010
Side effects of isoniazid and streptomycine in patients with pulmonary tuberculosis accompanying diabetes mellitus and diabetic foot syndrome
Source: Annual Congress 2008 - Clinical epidemiology of tuberculosis III
Year: 2008
Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
A study of the comorbidity of COPD and type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
The coexisting pulmonary tuberculosis and diabetes mellitus
Source: Eur Respir J 2006; 28: Suppl. 50, 26s
Year: 2006
Comparison of COPD patients with and without diabetes mellitus
Source: Virtual Congress 2020 – Diagnosis and management of COPD
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept